FNDC5/irisin is reduced in postmortem Alzheimer’s disease (AD) brains and in mouse models of AD (Lourenco et al., 2019), and reduced CSF irisin is associated with impaired cognition in mild cognitive impairment and AD patients. Here, FNDC5 is linked to early-onset autosomal dominant Alzheimer disease.